Comparison of Two Fragmentation Modalities in Femtosecond Laser-assisted Cataract Surgery (SLICES)
Primary Purpose
Cataract
Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
nuclear lens fragmentation in 8 pieces
nuclear lens fragmentation in 16 pieces
Sponsored by
About this trial
This is an interventional treatment trial for Cataract focused on measuring femtosecond laser-assisted cataract surgery, nuclear lens fragmentation
Eligibility Criteria
Inclusion Criteria:
- patient aged ≥ 18 years old
- first Femtosecond Laser-assisted Cataract Surgery scheduled
- cataract density ≥ 3 according to the lens opacities classification system (LOCS)
Exclusion Criteria:
- corneal guttata, uncontrolled glaucoma
- shallow depth of anterior chamber
- patient's refusal to participate in the study
- pregnant or breast feeding patient
- patient under legal protection
- no health coverage
Sites / Locations
- Fondation Opthalmologique A de Rothschild
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
16 pieces fragmentation
8 pieces fragmentation
Arm Description
Outcomes
Primary Outcome Measures
energy delivered for lens nucleus aspiration during phacoemulsification
ultrasound power delivered (measured in Hertz)
Secondary Outcome Measures
Full Information
NCT ID
NCT02898909
First Posted
September 8, 2016
Last Updated
December 10, 2019
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
1. Study Identification
Unique Protocol Identification Number
NCT02898909
Brief Title
Comparison of Two Fragmentation Modalities in Femtosecond Laser-assisted Cataract Surgery
Acronym
SLICES
Study Type
Interventional
2. Study Status
Record Verification Date
December 2019
Overall Recruitment Status
Terminated
Why Stopped
Major inclusion difficulties
Study Start Date
November 15, 2016 (Actual)
Primary Completion Date
December 21, 2017 (Actual)
Study Completion Date
December 10, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Femtosecond laser-assisted cataract surgery consists in nuclear lens fragmentation, followed by ultrasound phacoemulsification of nuclear lens, which is then removed.
It can be assumed that fragmenting the nuclear lens in more pieces could facilitate the post-laser ultrasound phacoemulsification to extract the lens, with a lesser amount of ultrasonic energy.
The decrease of ultrasonic energy delivered during cataract surgery is beneficial to the patient because it optimizes the vitality of corneal endothelial cells, which ensure corneal transparency.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract
Keywords
femtosecond laser-assisted cataract surgery, nuclear lens fragmentation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
5 (Actual)
8. Arms, Groups, and Interventions
Arm Title
16 pieces fragmentation
Arm Type
Experimental
Arm Title
8 pieces fragmentation
Arm Type
Active Comparator
Intervention Type
Device
Intervention Name(s)
nuclear lens fragmentation in 8 pieces
Intervention Type
Device
Intervention Name(s)
nuclear lens fragmentation in 16 pieces
Primary Outcome Measure Information:
Title
energy delivered for lens nucleus aspiration during phacoemulsification
Description
ultrasound power delivered (measured in Hertz)
Time Frame
approximatively 15 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patient aged ≥ 18 years old
first Femtosecond Laser-assisted Cataract Surgery scheduled
cataract density ≥ 3 according to the lens opacities classification system (LOCS)
Exclusion Criteria:
corneal guttata, uncontrolled glaucoma
shallow depth of anterior chamber
patient's refusal to participate in the study
pregnant or breast feeding patient
patient under legal protection
no health coverage
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean-Luc FEBBRARO, MD
Organizational Affiliation
Fondation OPH A de Rothschild
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fondation Opthalmologique A de Rothschild
City
Paris
ZIP/Postal Code
75019
Country
France
12. IPD Sharing Statement
Learn more about this trial
Comparison of Two Fragmentation Modalities in Femtosecond Laser-assisted Cataract Surgery
We'll reach out to this number within 24 hrs